Sclerostin Is a Novel Secreted Osteoclast-derived Bone Morphogenetic Protein Antagonist with Unique Ligand Specificity

This publication has 24 references indexed in Scilit:

• Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
  Human Molecular Genetics, 2001
• Mutation and Analysis of Dan, the Founding Member of the Dan Family of Transforming Growth Factor β Antagonists
  Molecular and Cellular Biology, 2001
• Bone Development
  Annual Review of Cell and Developmental Biology, 2000
• Structure and Expression of a Novel Member, FGF-16, of the Fibroblast Growth Factor Family
  Biochemical and Biophysical Research Communications, 1998
• Differentiation and Transforming Growth Factor-β Receptor Down-regulation by Collagen-α2β1 Integrin Interaction Is Mediated by Focal Adhesion Kinase and Its Downstream Signals in Murine Osteoblastic Cells
  Journal of Biological Chemistry, 1997
• Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
  Genes & Development, 1996
• Cystine knots
  Current Opinion in Structural Biology, 1995
• Bone and cartilage differentiation
  Current Opinion in Genetics & Development, 1994
• Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells
  Journal of Bone and Mineral Research, 1994
• High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development
  The Journal of cell biology, 1994